CisFRAD (GORTEC 2015-02)

Virtual 2020 ESMO Congress

Standard versus fractionated high dose cisplatin concomitant with radiotherapy in locally advanced head & neck squamous cell cancer (LA-HNSCC): Results of the GORTEC 2015-02 CisFRad randomized trial
Publication PDF

C. Borel, X. Sun, A. Coutte, G. Bera, S. Zanetta, M. Alfonsi, G. Janoray, T. Chatellier, M. Garcia-Ramirez, E. Gherga, Y.Hammoud, N. Etienne-Selloum, A. Pechery, M.H. Girard-Calais, M. Velten, J-P. Pignon, M. Wanneveich, J.Bourhis